Severe/Very Severe COVID-19 Illness (DBCOND0128244)
Identifiers
- Synonyms
- Not Available
Associated Data
- Indicated Drugs and Targets
- Not Available
- Clinical Trials
Identifier Title Drug(s) Purpose Phase Status NCT04745637 Managed Access Programs for INC424, Ruxolitinib Not Available Not Available available NCT04337359 Ruxolitinib Managed Access Program (MAP) for Patients Diagnosed With Severe/Very Severe COVID-19 Illness Not Available Not Available no_longer_available